Revolution Medicines Inc   (RVMD)
Other Ticker:  

Revolution Medicines Inc's Customers Performance


RVMD's Source of Revenues

List of RVMD Customers

for the same period Revolution Medicines Inc

List of RVMD Customers

Revolution Medicines Inc's Comment on Sales, Marketing and Customers

  News about Revolution Medicines Inc Contracts

Revolution Medicines Unveils RMC-6236: Transforming Cancer Treatment with a Breakthrough RAS(ON) Inhibitor.

Revolution Medicines, a leading biotechnology company at the forefront of cancer research, has recently announced a groundbreaking discovery in the field of oncology. The company's publication and presentation on their investigational RAS(ON) multi-selective tri-complex inhibitor, RMC-6236, at the AACR 2024 Conference in San Diego has garnered significant attention. This development marks a momentous stride towards a comprehensive strategy to combat oncogenic RAS proteins beyond the G12C mutation, using both small molecules and immuno-oncology.Revolution Medicines' Game-Changing Approach:RAS proteins are notorious drivers of tumor growth and have long eluded effective therapeutic interventions. However, Revo...

RVMD's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

Revolution Medicines Inc 3,960.79 29.52 -331.34 -
SUBTOTAL 0.00 0.00 0.00 -


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com